Thursday, 5 November 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 30, 2026

SpaceX’s IPO could open the floodgates — and secondaries are booming in the meantime

View original at finance.yahoo.com
“SpaceX also just did a tender at an $800 billion valuation, and we see a ton of interest on our platform at Rainmaker in continuing to buy into the secondary.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • More market cap is now housed in the private markets

    80% confidence

  • OpenAI and Anthropic are now over a trillion dollars of combined market cap, though three or four years ago they were valued much lower

    80% confidence

  • SpaceX could create a reset in the IPO market if it were to go public this year

    80% confidence

  • Last year was Rainmaker's biggest year, trading over $1 billion worth of secondaries

    80% confidence

  • Lining up banks is a pretty big signal that SpaceX is serious about IPO, not just playing games

    80% confidence

  • SpaceX is already pricing well above where the last tender round was and getting closer to that trillion and a half that they had discussed as a potential IPO price

    80% confidence

  • SpaceX has a business that is largely profitable and has dominance in their two key businesses

    80% confidence

  • Elon Musk famously said he wouldn't take SpaceX public until rockets were flying to Mars regularly

    80% confidence

  • If anyone can build data centers in space cooled by space and run by solar panels directly from the sun, Elon's probably the guy

    80% confidence

  • Jeff Bezos is going to launch a communication network to compete with Starlink

    80% confidence

  • SpaceX IPO will likely be a sliver deal, only 5% of their company that's technically available

    80% confidence

  • SpaceX will get a premium multiple well above what typical market rates would be, given the Elon halo effect

    80% confidence

  • The news that SpaceX may be considering various transactions with xAI and Tesla has caused a temporary pause in the market for SpaceX shares

    80% confidence

  • Private companies are staying private much longer now, with many companies that would be top 30 in the S&P 500 historically going public years earlier

    80% confidence

  • Companies should open up private secondary capability as a great way to develop price discovery well in advance of the IPO

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com
SpaceX’s IPO could open the floodgates — and secondaries are booming in the meantime — Source | Via News | ViaNews EU